12.4 Oncology Support & Oral Anticancer Medicines
Key Takeaways
- A fever of 38 degrees Celsius or above in a patient receiving chemotherapy is a medical emergency requiring immediate hospital assessment, not over-the-counter antipyretics.
- Cytotoxic tablets and capsules must not be crushed, split or opened; contact the prescriber for an alternative if the patient cannot swallow.
- Capecitabine markedly potentiates warfarin, and hand-foot syndrome or diarrhoea should prompt the patient to stop and contact the treating team.
- Strong CYP2D6 inhibitors such as paroxetine and fluoxetine reduce tamoxifen activation to endoxifen, so antidepressant selection matters in breast cancer.
- Oral anticancer regimens are commonly cycled with rest periods, so the cycle and next start date must be confirmed at every supply rather than assumed to be continuous.
12.4 Oncology Support & Oral Anticancer Medicines
Quick Answer: APC names oncology as an exam content area. Community pharmacists now dispense oral anticancer medicines routinely, so the examinable skills are safe handling, recognising febrile neutropenia as an emergency, screening over-the-counter requests against thrombocytopenia and interactions, and supporting adherence to complex cycled regimens.
Oncology reaches community pharmacy through three doors: oral anticancer medicines dispensed on ordinary prescriptions, supportive care for people between hospital cycles, and over-the-counter requests from patients whose blood counts change the safety of everyday products. All three sit inside Standards 3.2 and 3.3.
Safe handling of cytotoxic and hazardous medicines
Oral does not mean harmless to handle.
- Wear gloves when counting or handling; prefer supplying in the original manufacturer's pack rather than repacking
- Do not crush, split or open cytotoxic tablets or capsules; if the person cannot swallow, contact the prescriber for an alternative rather than improvising
- Avoid including cytotoxics in dose administration aids unless a specific risk assessment supports it
- Staff who are pregnant, breastfeeding or trying to conceive should follow the pharmacy's policy on handling hazardous medicines
- Know your spill procedure and where the spill kit is
- Counsel patients and carers on handling: gloves for carers, careful handling of vomit and body waste for a defined period after dosing, and returning unused medicines to the pharmacy rather than the bin
Oral anticancer medicines — high-yield counselling
| Medicine | Counselling and safety essentials |
|---|---|
| Capecitabine | Take within about 30 minutes after food; hand-foot syndrome (painful red palms and soles) and diarrhoea are dose-limiting — tell the patient to stop and contact the treating team rather than push on; markedly potentiates warfarin, causing dangerous INR rises; DPD deficiency increases toxicity risk |
| Methotrexate (non-oncology) | Weekly, not daily. A daily direction without an explicit verified specialist protocol must be resolved with the prescriber before supply |
| Tamoxifen | Adherence over years is the main determinant of benefit; hot flushes are common; venous thromboembolism and endometrial changes need awareness — report calf pain, breathlessness or abnormal vaginal bleeding; strong CYP2D6 inhibitors such as paroxetine and fluoxetine reduce activation to endoxifen, so an antidepressant choice matters here |
| Aromatase inhibitors (anastrozole, letrozole, exemestane) | Arthralgia is the leading reason for discontinuation — normalise it and offer strategies rather than let the patient quit silently; bone density loss requires monitoring, calcium and vitamin D review |
| Targeted oral agents (kinase inhibitors and similar) | Many have significant food and interaction restrictions, including grapefruit and acid-suppressing medicines; always check the specific agent rather than generalising |
Cycled regimens are an adherence hazard. Many oral regimens run, for example, two weeks on and one week off. A patient who "just keeps taking them" can be seriously over-treated. Confirm the cycle, the rest period and the next start date at every supply, and never assume a repeat means continuous therapy.
Febrile neutropenia — the emergency you must not miss
A person receiving chemotherapy who develops a fever of 38 °C or above, or who feels acutely unwell with rigors, requires immediate hospital assessment. Do not sell paracetamol and send them home; paracetamol can mask the fever that is the only visible sign.
Other urgent escalations: uncontrolled vomiting or diarrhoea with dehydration risk, mouth ulceration preventing eating or drinking, breathlessness, unexplained bruising or bleeding, and new severe pain.
Over-the-counter screening in a patient on chemotherapy
| Request | Concern |
|---|---|
| Aspirin or an NSAID | Bleeding risk with thrombocytopenia; renal risk with nephrotoxic regimens |
| Paracetamol for fever | May mask febrile neutropenia — assess before supplying |
| Herbal products, especially St John's wort | Potent enzyme induction can reduce anticancer drug concentrations; high-dose antioxidants may interact with treatment intent |
| Live vaccines | Generally avoided during significant immunosuppression; inactivated vaccines are encouraged and timed with the treating team |
| Constipation remedies | Frequently needed — 5-HT3 antagonists such as ondansetron and opioids both constipate |
Ask, do not assume. Many patients do not consider complementary products to be "medicines" and will not mention them unless invited.
Supportive care essentials
- Nausea and vomiting — prevention beats rescue. Regimens combine a 5-HT3 antagonist, dexamethasone and, for highly emetogenic protocols, an NK1 antagonist. Counsel on taking antiemetics as scheduled, not only when nauseated, and warn about ondansetron-induced constipation.
- Mucositis — bland mouth care, saline or bicarbonate rinses, avoiding alcohol-containing mouthwashes, and escalation if the person cannot eat or drink.
- Cancer pain — opioids are appropriate and should be titrated; always co-prescribe or recommend a laxative with a regular opioid, and counsel on breakthrough dosing versus background dosing.
- Skin and nail care — sun protection is important with photosensitising agents; hand-foot syndrome prevention includes emollients and avoiding friction and heat.
- Fertility, contraception and pregnancy — many agents are teratogenic; contraception advice extends beyond the treatment period and applies to both men and women.
Communication and cultural safety
Oncology conversations carry fear. Use plain language, check understanding, and be careful with prognosis language that is not yours to give. Offer a private consultation space, involve carers with the patient's consent, and use an interpreter where language is a barrier rather than relying on a family member. If a patient raises unproven "cures" they have read about, respond with honest, evidence-based information and encourage them to discuss it with the oncology team — do not ridicule, and do not endorse.
Exam mindset
Oncology items rarely ask you to choose a chemotherapy regimen. They ask whether you will recognise febrile neutropenia, whether you will check the cycle before supplying, whether you will spot capecitabine plus warfarin, and whether you will refuse to crush a cytotoxic tablet. Those are pharmacist decisions and they are exactly what Standards 3.2 and 3.3 assess.
PBS access and supply logistics
Many oral anticancer medicines are Authority required on the PBS, and the authority conditions are specific — a particular line of therapy, a documented disease stage, or evidence of prior treatment. Practical consequences at the counter:
- Check that the authority approval number or streamlined code is present and matches the item and quantity before you supply
- Confirm the quantity and repeats fit the prescribed cycle rather than a generic monthly assumption
- Where an item is not PBS-subsidised for that indication, the private cost can be substantial — tell the patient before you order rather than after
- Some medicines are supplied through hospital or specialist pharmacy arrangements; know when to redirect rather than promise a supply you cannot deliver
Dose administration aids are the other recurring logistics decision. Cytotoxic and hazardous medicines are generally excluded from packing because of contamination risk and because cycled dosing does not fit a weekly blister. If the patient needs adherence support, use a written cycle calendar, reminders and carer involvement instead.
A patient who had chemotherapy eight days ago telephones reporting a temperature of 38.4 degrees Celsius and feeling shivery. What is the correct pharmacist response?
A carer asks whether she can crush her husband's capecitabine tablets because he is struggling to swallow them. What is the most appropriate response?
A woman taking tamoxifen after breast cancer surgery is being started on an antidepressant. Which consideration is most important to raise with the prescriber?
A patient on active chemotherapy asks for ibuprofen for a headache and mentions recent easy bruising. What is the main concern?